Yi Fei Yang

Director/Board Member at RED PHASE INC.

49 year

Electronic Technology

Health Services

Commercial Services

Profile

Yi Fei Yang currently works at China Tourism & Culture Investment Group Co., Ltd., as Independent Director from 2022, Red Phase, Inc., as Independent Director from 2021, and Xiamen Zeesan Biotech Co., Ltd., as Independent Director from 2021.

Yi Fei Yang active positions

Companies	Position	Start
RED PHASE INC.	Director/Board Member	2021-03-21
CHINA TOURISM AND CULTURE INVESTMENT GROUP CO.,LTD	Director/Board Member	2022-12-19
Xiamen Zeesan Biotech Co., Ltd. Xiamen Zeesan Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Xiamen Zeesan Biotech Co., Ltd. engages in the research and development, production, and sales of molecular diagnostic technology, molecular diagnostic reagents, and molecular diagnostic instruments. It specializes in molecular diagnostic reagent products and molecular diagnostic instrument products, provides the basis for disease screening and diagnosis, drug selection and efficacy monitoring of infectious diseases including respiratory disease and human papillomavirus infection, hematologic oncology, personalized medicine and genetic diseases. The company was founded on June 12, 2010 and is headquartered in Xiamen, China.	Director/Board Member	2021-08-22

All active positions of Yi Fei Yang

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Yi Fei Yang's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
RED PHASE INC.	Electronic Technology
CHINA TOURISM AND CULTURE INVESTMENT GROUP CO.,LTD	Commercial Services

Private companies	1
Xiamen Zeesan Biotech Co., Ltd. Xiamen Zeesan Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Xiamen Zeesan Biotech Co., Ltd. engages in the research and development, production, and sales of molecular diagnostic technology, molecular diagnostic reagents, and molecular diagnostic instruments. It specializes in molecular diagnostic reagent products and molecular diagnostic instrument products, provides the basis for disease screening and diagnosis, drug selection and efficacy monitoring of infectious diseases including respiratory disease and human papillomavirus infection, hematologic oncology, personalized medicine and genetic diseases. The company was founded on June 12, 2010 and is headquartered in Xiamen, China.	Health Services